Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	32.93	46.09	34.68
Graham Fair Price	-75.75	4.04	16.67
PEG	354.04	2.90	-0.64
Price/Book	19.57	2.45	2.05
Price/Cash Flow	1307.23	-258.60	18.38
Prices/Earnings	1825.99	-307.09	15.94
Price/Sales	-0.13	4.25	4.26
Price/FCF	1307.23	-258.60	18.38
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-61.34	0.22	0.58
Operating Margin	-10.84	0.15	0.17
ROA	-95.62	< 0.005	< 0.005
ROE	0.03	< 0.005	-93.79
ROIC	0.02	< 0.005	-81.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.48	0.19	146.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	0.01	-58.86
EPS QOQ	-0.25	-1.06	-324.19
FCF QOQ	2.37	-1.08	-54.44
Revenue QOQ	< 0.005	0.13	13586.56
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	290.99	180.70	-37.90
Days Sales Outstanding (DSO)	231.40	275.99	19.27
Inventory Turnover	0.31	0.50	61.04
Debt/Capitalization	0.68	0.78	14.08
Quick Ratio	3.08	3.15	2.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.59	19.07	-2.69
Cash	8.59	6.91	-19.57
Capex	-0.26	-0.18	30.31
Free Cash Flow	2.19	-0.18	-91.73
Revenue	9.44	11.00	16.51
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.26	4.44	4.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.98	25.54	59.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating